Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Astrana Health Inc

Healthcare US ASTH

23.44USD
-1.28(5.18%)

Last update at 2026-03-10T20:00:00Z

Day Range

22.8924.95
LowHigh

52 Week Range

23.1263.20
LowHigh

Fundamentals

  • Previous Close 24.72
  • Market Cap1254.57M
  • Volume415041
  • P/E Ratio37.23
  • Dividend Yield-%
  • EBITDA109.47M
  • Revenue TTM2250.57M
  • Revenue Per Share TTM46.98
  • Gross Profit TTM 268.76M
  • Diluted EPS TTM0.73

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax 89.84M 86.62M 77.75M 8.87M 25.84M
Minority interest 2.87M 1.48M 24.56M 84.45M 3.56M
Net income 60.72M 45.17M 68.92M -23.75200M 14.12M
Selling general administrative 112.60M 77.67M 62.08M 15.59M 41.48M
Selling and marketing expenses - - - - -
Gross profit 214.96M 199.48M 177.77M 21.70M 74.53M
Reconciled depreciation 17.75M 17.54M 17.52M 18.35M 18.75M
Ebit 110.52M 115.81M 91.69M 21.92M 34.41M
Ebitda 128.27M 133.35M 109.21M 40.27M 52.69M
Depreciation and amortization 17.75M 17.54M 17.52M 18.35M 18.28M
Non operating income net other - -9.72900M -15.03700M 107.42M -1.84678M
Operating income 84.61M 104.27M 98.18M 6.09M 34.41M
Other operating expenses 1302.05M 1039.90M 675.74M 364.16M 526.20M
Interest expense 16.10M 7.92M 5.39M 2.53M 4.73M
Tax provision 31.99M 36.09M 28.45M 56.11M 8.17M
Interest income 14.21M 1.98M 1.57M 2.81M 2.02M
Net interest income -1.89400M -5.94400M -3.82300M -6.68600M -2.70938M
Extraordinary items - - - - -
Non recurring - - - - 0.63M
Other items - - - - -
Income tax expense 31.99M 40.88M 31.69M 9.18M 8.17M
Total revenue 1386.66M 1144.16M 773.91M 370.25M 560.62M
Total operating expenses 130.34M 95.21M 79.59M 15.62M 40.12M
Cost of revenue 1171.70M 944.68M 596.14M 348.54M 486.09M
Total other income expense net 7.12M -11.70500M -16.60800M 4.90M -8.57404M
Discontinued operations - - - - -
Net income from continuing ops 57.85M 50.53M 49.29M 122.32M 17.67M
Net income applicable to common shares - 49.05M 73.86M 37.87M 14.12M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 1354.89M 933.36M 966.21M 867.36M 817.49M
Intangible assets 87.84M 71.65M 76.86M 82.81M 86.98M
Earning assets - - - - -
Other current assets 22.86M 17.45M 14.80M 18.64M 16.80M
Total liab 861.38M 522.59M 407.67M 356.72M 372.34M
Total stockholder equity 712.72M 614.22M 542.56M 448.17M 330.82M
Deferred long term liab - - 3.04M 9.13M 10.96M
Other current liab 179.59M 184.10M 132.82M 88.51M 78.28M
Common stock 0.05M 0.05M 0.05M 0.04M 0.04M
Capital stock 0.05M 0.05M 0.05M 0.04M 0.04M
Retained earnings 286.28M 243.13M 182.42M 137.25M 69.77M
Other liab - - 23.30M 23.90M 10.96M
Good will 243.28M 278.83M 269.05M 246.42M 239.05M
Other assets 417.69M - 6.06M 6.50M 55.29M
Cash 288.45M 293.81M 288.03M 233.10M 193.47M
Cash and equivalents - - - - -
Total current liabilities 222.69M 218.67M 148.61M 114.72M 114.99M
Current deferred revenue 1.61M 0.74M 0.53M 16.80M 12.99M
Net debt 183.38M 27.21M -58.66300M -32.11400M 67.08M
Short term debt 15.28M 24.75M 4.79M 3.90M 14.17M
Short long term debt 9.38M 19.50M 0.62M 0.78M 10.89M
Short long term debt total 471.84M 321.01M 229.36M 200.98M 260.56M
Other stockholder equity 426.39M 371.04M 360.10M 310.88M 261.01M
Property plant equipment - - 128.98M 68.63M 48.46M
Total current assets 638.50M 461.51M 428.12M 404.46M 338.58M
Long term investments 48.22M 32.17M 40.30M 42.61M 47.92M
Net tangible assets - - 213.97M 118.70M 119.02M
Short term investments 2.38M 2.50M 5.57M 53.42M 67.69M
Net receivables 324.80M 147.75M 119.73M 99.31M 60.62M
Long term debt 425.30M 258.94M 203.39M 182.92M 230.21M
Inventory - - - -67.21700M -
Accounts payable 15.17M 9.07M 10.47M 5.51M 9.55M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - 2.19M 5.94M 0.09M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - 0.05M 0.04M 0.04M
Preferred stock total equity - - - - -
Retained earnings total equity - - 192.68M 143.63M 69.77M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 257.69M 2.22M 4.56M 5.93M 19.41M
Deferred long term asset charges - - - - -
Non current assets total 716.40M 471.85M 538.09M 462.90M 478.91M
Capital lease obligations 37.16M 42.58M 25.36M 17.29M 19.45M
Long term debt total - - 203.39M 182.92M 230.21M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -65.52300M 34.28M 32.37M 107.96M -129.69545M
Change to liabilities - 18.80M 3.22M 6.82M -13.87921M
Total cashflows from investing activities - -7.11300M 16.54M 95.49M -180.63064M
Net borrowings - -0.82800M -57.96500M -0.10500M 281.35M
Total cash from financing activities 3.42M -20.08500M -47.74800M -51.69600M 163.33M
Change to operating activities - 36.13M -18.19900M -1.22000M -21.50909M
Net income 57.85M 50.53M 49.29M 122.32M 17.67M
Change in cash 6.12M 54.93M 39.13M 89.96M -3.62654M
Begin period cash flow 288.03M 233.10M 193.97M 104.01M 107.64M
End period cash flow 294.15M 288.03M 233.10M 193.97M 104.01M
Total cash from operating activities 68.23M 82.13M 70.33M 46.16M 13.67M
Issuance of capital stock 0.00000M 0.00100M 40.13M -0.00000M 0.75M
Depreciation 17.75M 17.54M 17.52M 18.35M 18.75M
Other cashflows from investing activities - -18.45700M 0.06M -11.30400M -49.89351M
Dividends paid 62.07M 14.03M 31.09M 51.32M 61.72M
Change to inventory 12.15M 31.37M 1.02M -5.81100M -29.56291M
Change to account receivables -20.56800M -36.96300M -21.63400M 3.01M 9.28M
Sale purchase of stock -10.19200M -9.25000M -5.73900M -0.53700M -7.56968M
Other cashflows from financing activities -5.00600M 7.62M 187.48M -1.03700M 286.98M
Change to netincome - -3.70900M -1.99700M -106.66800M 2.27M
Capital expenditures 28.53M 22.94M 19.22M 1.16M 1.04M
Change receivables - -28.76700M -26.79600M 15.60M -5.80085M
Cash flows other operating - 26.80M 4.92M -11.61000M -5.34146M
Exchange rate changes - - - - -
Cash and cash equivalents changes - 54.93M 39.13M 89.96M -3.62654M
Change in working capital -23.38800M -9.58300M -20.12100M 10.81M -22.77152M
Stock based compensation 22.04M 16.10M 6.75M 3.38M 1.55M
Other non cash items 6.42M 15.22M 22.85M -102.08400M 5.27M
Free cash flow 39.70M 59.19M 51.11M 45.00M 12.63M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ASTH
Astrana Health Inc		 -1.28 5.18% 23.44 37.23 23.04 0.56 1.68 0.64 11.21
HCA
HCA Holdings Inc		 -7.49 1.37% 537.64 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR		 0.05 0.36% 14.02 16.87 9.44 0.42 0.78 0.79 5.37
FSNUF
Fresenius SE & Co. KGaA		 - -% 54.35 16.76 9.62 0.42 0.79 0.78 5.31
JDHIY
JD Health International Inc		 - -% 9.08 62.50 35.97 0.30 2.32 0.16 3.90

Reports Covered

Stock Research & News

View All

Profile

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1994 and is headquartered in Alhambra, California.

Astrana Health Inc

1668 S. Garfield Avenue, Alhambra, CA, United States, 91801

Key Executives

Name Title Year Born
Dr. Kenneth T. Sim M.D. Co-Founder & Executive Chairman 1955
Mr. Brandon K. Sim M.S. President & CEO 1994
Dr. Thomas S. Lam M.D., M.P.H. Co-Founder & Vice Chairman 1949
Mr. Chandan Basho M.B.A. CFO & COO 1983
Dr. WaiChow Young M.D., M.P.H. Chief Administrative Officer 1948
Mr. John Vong CPA, CGMA, M.B.A. Chief Accounting Officer 1973
Ms. Rita Pew M.B.A. Vice President of People & Operations NA
Dr. Jeremy R. Jackson M.D. Chief Quality Officer NA
Mr. Neil Ahuja President of Provider Solutions NA
Dr. Carlos Palacios M.D. Chief Medical Officer for Texas NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.